Ischemix
63 Great Rd Ste 200
Maynard, MA 01754
Ischemix Inc., located in Maynard, MA, is focused on developing novel proprietary cytoprotective compounds aimed at treating serious diseases and conditions. Their lead compound, CMX-2043, is currently in preclinical development for traumatic brain injury (TBI) and has demonstrated significant therapeutic potential in various preclinical studies.
CMX-2043, a new chemical entity with multi-modal activity, shows promise in addressing the complex challenges associated with TBI. The compound is supported by multiple issued patents for its composition and methods of use, indicating its innovative approach to treatment.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Foursquare.